GW25-e3203 Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study

GW25-e3203 Hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) for congestive heart failure: a randomized, double-blind, placebo-controlled study

Objectives This study was designed to confirm hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) at the prespecified dose in patients with congestive heart failure compared to placebo when both were added to standard care.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2014-10, Vol.64 (16), p.C182-C183
Hauptverfasser: Pengbo, Wang, Jie, Huang, Huiqiong, Tan, Wenxian, Liu, Jian, Zhang, Zhongkai, Liao, Litian, Yu, Yi, Mao, Shaodong, Ye, Lei, Feng, Yuhui, Zhang, Yang, Wang, Wei, Li, Xiaojun, Luan, Sijia, Wang, Shugong, Bai, Guogan, Wang
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Drug therapy
Heart failure
Internal Medicine
Medical research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives This study was designed to confirm hemodynamic effects of short-term infusion of recombinant human atrial natriuretic peptide (rhANP) at the prespecified dose in patients with congestive heart failure compared to placebo when both were added to standard care.
ISSN:0735-1097
1558-3597
DOI:10.1016/j.jacc.2014.06.844